Overview
Sarah Reime practices practicing medicine in Halle, Germany.
Ms. Reime is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Metabolic Acidosis, Cerebral Hypoxia, and Prostate Cancer.
She is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sarah Reime
Is Sarah Reime a top-rated expert for Metabolic Acidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Sarah Reime is classified as an Distinguished expert for Metabolic Acidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sarah Reime participate in research or clinical trials?
Yes. Sarah Reime has published 22 articles and abstracts on conditions like Metabolic Acidosis. You can view a list of Sarah Reime's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Metabolic AcidosisMs. Reime isDistinguished. Learn about Metabolic Acidosis.
- Advanced
- Cerebral HypoxiaMs. Reime isAdvanced. Learn about Cerebral Hypoxia.
- Experienced
- Prostate CancerMs. Reime isExperienced. Learn about Prostate Cancer.